These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 523271)

  • 1. [Evaluation of the effectiveness of prodigiozan in acute respiratory viral infections in young infants].
    Raĭnite-Audinene AB; Uspenskiĭ IuS; Priĭmiagi LS; Kremerman IB; Voloshina LZ
    Pediatriia; 1979 Dec; (12):44-6. PubMed ID: 523271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL; Andrushchuk AA; Korzhenevskiĭ AF; Krivokhatskaia LD
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the effect of prodigiozan on the course of acute respiratory viral infections].
    Raĭnite-Audinene AB; Priĭmiagi LS; Kremerman IB; Lukoshiavichius AA
    Pediatriia; 1983 Apr; (4):26-8. PubMed ID: 6192389
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of a number of therapeutic agents on immunity and nonspecific reactivity in respiratory viral infections in children].
    Ivanova VV; Kurbatova GP; Aksenova OA; Blagoslovenskiĭ GS; Kamal'dinova EG
    Pediatriia; 1985 Sep; (9):35-8. PubMed ID: 4080480
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of prodigiozan in the overall treatment of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Tsymbaliuk GF; Kostromina VP; Medvedeva MM
    Probl Tuberk; 1980 Jan; (1):33-6. PubMed ID: 6966060
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of prodigiozan and zymosan in treating children with viral hepatitis A].
    Lebenzon SS; Maianskiĭ DN; Gavrilova NI; Kutina SN
    Pediatriia; 1988; (6):27-30. PubMed ID: 3186403
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of levamisole as an interferon inducer in young infants with respiratory viral infections].
    Raĭnite-Audinene AB; Priĭmiagi LS; Kremerman IB; Rozhukas AA
    Pediatriia; 1985 Sep; (9):38-40. PubMed ID: 2417187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in using prodigiozan in the overall treatment of suppurative surgical diseases in children].
    Zhukov MD; Geĭn VV
    Klin Khir (1962); 1979 Jun; (6):38-40. PubMed ID: 379414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Content of total immunoglobulin E of the blood serum in patients with acute viral hepatitis A and B undergoing prodigiozan and ibuprofen treatment].
    Andreĭchin MA; Rudchik AS
    Sov Med; 1988; (12):117-8. PubMed ID: 3242111
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunobiological aspects of using polysaccharides of bacterial origin for treatment of young children with acute viral respiratory diseases].
    Andrushchuk AO; Rudkovskaia NIe; Lisiana TA
    Pediatr Akus Ginekol; 1972 Oct; 5():5-6. PubMed ID: 4572663
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM; Rychnev VE
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of prodigiozan and lysozyme in ENT organ diseases].
    Brofman AV
    Zh Ushn Nos Gorl Bolezn; 1980; 1():46-51. PubMed ID: 7361524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative assessment of pathogenic agents in the combined treatment of respiratory organ tuberculosis].
    Karapetian ET; Markova EF; Gasparian AA; Apresian EA; Saakian AL
    Probl Tuberk; 1982 Mar; (3):40-4. PubMed ID: 7088922
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA; Rushchak VA; Maliuk VI; Vel'tman RV; Polner RA
    Pediatr Akus Ginekol; 1979; (3):16-8. PubMed ID: 379787
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the use of prodigiozan in acute pneumonia and hospital respiratory viral infections in a pediatric department of a district hospital].
    Pedanova VM; Smorchkov AP; Furer NM; Goldberg GE; Sizova LP
    Antibiotiki; 1973 Oct; 18(10):935-8. PubMed ID: 4587063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prodigiozan in the therapy of destructive pulmonary tuberculosis].
    Kornilova ZKh; Svitneva AS
    Probl Tuberk; 1980 Jan; (1):30-2. PubMed ID: 7367422
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of prodigiozan for the nonspecific prevention of influenza and ARD among frequently ill schoolchildren].
    Ignat'eva GS; Gagarinova VM; Ivanova AM; Rodina MA; Protasova SF; Markelova NF; Katorgina LG; Perova NS
    Pediatriia; 1990; (9):67-70. PubMed ID: 2147993
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of using lymphocytic interferon on children with acute respiratory viral infections complicated by pneumonia].
    Korniienko AB
    Pediatr Akus Ginekol; 1980; (2):16-7. PubMed ID: 6155658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immediate hypersensitivity reaction in acute viral hepatitis A and B treated with interferon inducers].
    Andreĭchin MA; Rudchik AS; Borak VF
    Sov Med; 1989; (11):10-4. PubMed ID: 2626696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.